CNN

U.S. Food and Drug Administration Approves Humulin® R U-500 KwikPen®

INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...
ConsumerAffairs

FDA approves four-dose Zepbound KwikPen for weight loss

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device. Lilly says the new pen expands patient choice, ...
The American Journal of Managed Care

FDA Approves Monthly KwikPen Option for Tirzepatide in Chronic Weight Management

FDA authorization now permits a 4-dose KwikPen presentation, consolidating one month of tirzepatide therapy into a single device for chronic weight management. LillyDirect self-pay pricing starts at ...
Business Wire

Amazon Pharmacy Expands Access to Eli Lilly’s Zepbound KwikPen for Weight Management

Amazon Pharmacy now offers customers transparent cash-pay pricing starting at $299 per month for the 2.5 mg KwikPen starter dose and convenient, fast home delivery. SEATTLE--(BUSINESS WIRE)--Amazon ...
Healio

FDA approves label expansion for Zepbound to be used with Eli Lilly’s KwikPen

Please provide your email address to receive an email when new articles are posted on . The Zepbound KwikPen allows patients to receive four doses of the drug in a single pen device. According to Eli ...
Becker's Hospital Review

Kroger pharmacies add Zepbound KwikPen

Kroger is now offering Zepbound KwikPen, a multidose version of Eli Lilly’s GLP-1 weight loss drug, at participating retail pharmacy locations. The rollout marks the first time self-pay patients may ...